Neutrophil	neutrophil	O	O	O	O
superoxide	superoxide	CHEMICALS	O	OTHERS	I
and	and	O	O	O	O
hydrogen	hydrogen	CHEMICALS	O	OTHERS	I
peroxide	peroxide	CHEMICALS	O	OTHERS	I
production	production	O	O	O	O
in	in	O	O	O	O
patients	patients	O	O	O	O
with	with	O	O	O	O
acute	acute	O	DISEASE	OTHERS	I
liver	liver	O	DISEASE	OTHERS	I
failure	failure	O	DISEASE	OTHERS	I
.	.	O	O	O	O

Defects	defects	O	O	O	O
in	in	O	O	O	O
superoxide	superoxide	CHEMICALS	O	OTHERS	I
and	and	O	O	O	O
hydrogen	hydrogen	CHEMICALS	O	OTHERS	I
peroxide	peroxide	CHEMICALS	O	OTHERS	I
production	production	O	O	O	O
may	may	O	O	O	O
be	be	O	O	O	O
implicated	implicated	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
high	high	O	O	O	O
incidence	incidence	O	O	O	O
of	of	O	O	O	O
bacterial	bacterial	O	DISEASE	OTHERS	I
infections	infections	O	DISEASE	OTHERS	I
in	in	O	O	O	O
patients	patients	O	O	O	O
with	with	O	O	O	O
acute	acute	O	DISEASE	OTHERS	I
liver	liver	O	DISEASE	OTHERS	I
failure	failure	O	DISEASE	OTHERS	I
(	(	O	O	O	O
ALF	alf	O	DISEASE	OTHERS	I
)	)	O	O	O	O
.	.	O	O	O	O

In	in	O	O	O	O
the	the	O	O	O	O
present	present	O	O	O	O
study	study	O	O	O	O
,	,	O	O	O	O
oxygen	oxygen	CHEMICALS	O	OTHERS	I
radical	radical	O	O	O	O
production	production	O	O	O	O
in	in	O	O	O	O
patients	patients	O	O	O	O
with	with	O	O	O	O
ALF	alf	O	DISEASE	OTHERS	I
due	due	O	O	O	O
to	to	O	O	O	O
paracetamol	paracetamol	CHEMICALS	O	OTHERS	I
overdose	overdose	O	DISEASE	OTHERS	I
was	was	O	O	O	O
compared	compared	O	O	O	O
with	with	O	O	O	O
that	that	O	O	O	O
of	of	O	O	O	O
healthy	healthy	O	O	O	O
volunteers	volunteers	O	O	O	O
.	.	O	O	O	O

Neutrophils	neutrophils	O	O	O	O
from	from	O	O	O	O
14	14	O	O	O	O
ALF	alf	O	DISEASE	OTHERS	I
patients	patients	O	O	O	O
were	were	O	O	O	O
stimulated	stimulated	O	O	O	O
via	via	O	O	O	O
the	the	O	O	O	O
complement	complement	O	O	O	O
receptors	receptors	O	O	O	O
using	using	O	O	O	O
zymosan	zymosan	O	O	O	O
opsonized	opsonized	O	O	O	O
with	with	O	O	O	O
ALF	alf	O	DISEASE	OTHERS	I
or	or	O	O	O	O
control	control	O	O	O	O
serum	serum	O	O	O	O
.	.	O	O	O	O

Superoxide	superoxide	CHEMICALS	O	OTHERS	I
and	and	O	O	O	O
hydrogen	hydrogen	CHEMICALS	O	OTHERS	I
peroxide	peroxide	CHEMICALS	O	OTHERS	I
production	production	O	O	O	O
by	by	O	O	O	O
ALF	alf	O	DISEASE	OTHERS	I
neutrophils	neutrophils	O	O	O	O
stimulated	stimulated	O	O	O	O
with	with	O	O	O	O
zymosan	zymosan	O	O	O	O
opsonized	opsonized	O	O	O	O
with	with	O	O	O	O
ALF	alf	O	DISEASE	OTHERS	I
serum	serum	O	O	O	O
was	was	O	O	O	O
significantly	significantly	O	O	O	O
reduced	reduced	O	O	O	O
compared	compared	O	O	O	O
with	with	O	O	O	O
the	the	O	O	O	O
control	control	O	O	O	O
subjects	subjects	O	O	O	O
(	(	O	O	O	O
P	p	O	O	OTHERS	I
<	<	O	O	O	O
0.01	0.01	O	O	O	O
)	)	O	O	O	O
.	.	O	O	O	O

This	this	O	O	O	O
defect	defect	O	O	O	O
persisted	persisted	O	O	O	O
when	when	O	O	O	O
zymosan	zymosan	O	O	O	O
opsonized	opsonized	O	O	O	O
by	by	O	O	O	O
control	control	O	O	O	O
serum	serum	O	O	O	O
was	was	O	O	O	O
used	used	O	O	O	O
(	(	O	O	O	O
P	p	O	O	OTHERS	I
<	<	O	O	O	O
0.05	0.05	O	O	O	O
)	)	O	O	O	O
.	.	O	O	O	O

Superoxide	superoxide	CHEMICALS	O	OTHERS	I
and	and	O	O	O	O
hydrogen	hydrogen	CHEMICALS	O	OTHERS	I
peroxide	peroxide	CHEMICALS	O	OTHERS	I
production	production	O	O	O	O
in	in	O	O	O	O
neutrophils	neutrophils	O	O	O	O
stimulated	stimulated	O	O	O	O
with	with	O	O	O	O
formyl-methionyl-leucyl-phenylalanine	formyl-methionyl-leucyl-phenylalanine	O	O	O	O
(	(	O	O	O	O
fMLP	fmlp	O	O	OTHERS	I
)	)	O	O	O	O
from	from	O	O	O	O
a	a	O	O	O	O
further	further	O	O	O	O
18	18	O	O	O	O
ALF	alf	O	DISEASE	OTHERS	I
patients	patients	O	O	O	O
was	was	O	O	O	O
unaffected	unaffected	O	O	O	O
compared	compared	O	O	O	O
with	with	O	O	O	O
control	control	O	O	O	O
neutrophils	neutrophils	O	O	O	O
.	.	O	O	O	O

Serum	serum	O	O	O	O
C3	c3	O	O	O	O
complement	complement	O	O	O	O
levels	levels	O	O	O	O
were	were	O	O	O	O
significantly	significantly	O	O	O	O
reduced	reduced	O	O	O	O
in	in	O	O	O	O
ALF	alf	O	DISEASE	OTHERS	I
patients	patients	O	O	O	O
compared	compared	O	O	O	O
with	with	O	O	O	O
control	control	O	O	O	O
subjects	subjects	O	O	O	O
(	(	O	O	O	O
P	p	O	O	OTHERS	I
<	<	O	O	O	O
0.0005	0.0005	O	O	O	O
)	)	O	O	O	O
.	.	O	O	O	O

These	these	O	O	O	O
results	results	O	O	O	O
demonstrate	demonstrate	O	O	O	O
a	a	O	O	O	O
neutrophil	neutrophil	O	O	O	O
defect	defect	O	O	O	O
in	in	O	O	O	O
ALF	alf	O	DISEASE	OTHERS	I
due	due	O	O	O	O
to	to	O	O	O	O
paracetamol	paracetamol	CHEMICALS	O	OTHERS	I
overdose	overdose	O	DISEASE	OTHERS	I
,	,	O	O	O	O
that	that	O	O	O	O
is	is	O	O	O	O
complement	complement	O	O	O	O
dependent	dependent	O	O	O	O
but	but	O	O	O	O
independent	independent	O	O	O	O
of	of	O	O	O	O
serum	serum	O	O	O	O
complement	complement	O	O	O	O
,	,	O	O	O	O
possibly	possibly	O	O	O	O
connected	connected	O	O	O	O
to	to	O	O	O	O
the	the	O	O	O	O
complement	complement	O	O	O	O
receptor	receptor	O	O	O	O
.	.	O	O	O	O

